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ABSTRACT
The aim of the study. The primary objec-
tive of this study was to determine the 
differences in the incidence of respiratory 
infections and septic episodes in patients 
who underwent early percutaneous trache-
otomy (ET) and in patients who underwent 
translaryngeal intubation i.e late trache-
otomy (LT). Secondary objectives were 
to determine the differences in the early 
mortality of patients, duration of mechani-
cal ventilation and length of  Intensive care 
unit (ICU) stay.
Materials and methods. The study included 
72 surgical and trauma patients older than 
18 years of age, treated at the ICU of the 
University Clinical Hospital Mostar who 
had undergone translaryngeal intubation 
and were mechanically ventilated for at 
least 48 hours. The basic criterion for inclu-
sion in the study was expected duration of 
mechanical ventilation of at least 14 days. 
Forty-eight hours after enrollment, patients 
were randomly divided into two groups. 
The first group of patients underwent ET 
after 2-4 days of mechanical ventilation; 
the second group underwent LT if they ex-
hibited longer episodes of hypoxemia after 
15 days. 
Results. The ET group of patients spent 
less time in mechanical ventilation and 
ICU. The ET group had a lower rate of 
VAS pneumonia (p=0.137), sepsis episodes 
(p=0.029) and mortality rate (p=0.056).
Conclusion. The results of our study sup-
port ET being performed 2–4 days from 
the start of mechanical ventilation. De-
spite a lack of power, we found significant 
benefits of ET regarding the incidence of 
pneumonia, sepsis, hospital mortality, du-
ration of mechanical ventilation and length 
of ICU stay
Key words: tracheotomy, mechanical ventila-
tion, intensive care unit, ventilator-associat-
ed pneumonia, treatment outcome, compli-
cations 
INTRODUCTION 
The optimal method of treating the airways 
and implementing the process of mechani-
cal ventilation  in patients who are unable 
to breathe spontaneously, has been the ob-
ject of clinicians’ interest for almost a hun-
dred years. (1) In comparison with trans-
laryngeal intubation, the benefits of early 
percutaneous tracheotomy (ET) include: 
prevention of serious injury to the larynx, 
greater airway safety, decreased airway re-
sistance, facilitated pulmonary hygiene, 
and oral cavity care which can reduce the 
incidence of developing lung infections, 
help to facilitate the weaning process of 
mechanical ventilation, and greater mobil-
ity and comfort of patients. (2)
Although the rate of tracheotomy proce-
dures, in particular percutaneous trache-
otomy, has, according to the literature, 
increased by 200% in recent years, the anal-
ysis of major databases still continues to 
show an unbalanced approach in regards to 
the time required to perform tracheotomy 
procedures, early or late, and the conflict-
ing and inconsistent results relating to the 
incidence of nosocomial infection, cardiac 
complications, duration of treatment, dura-
tion of mechanical ventilation, and survival 
rate of patients. (3)
Adesina et al. point out the reduced num-
ber of days on the ventilator and shorter 
treatment in the Intensive care unit (ICU) 
as benefits of ET; however, their study did 
not report a decrease in hospital mortality 
rate. (4) Shorter treatment in ICUs is cited 
in other studies as well, (5-7) while Mahafza 
et al. and Rumbak et al. reported a decrease 
in mortality rate as a benefit of ET too. (8,9) 
In a study by Brook et al., the reduction of 
hospital costs is cited to be one of the ben-
efits, which is not to be disregarded. (10) 
The majority of previous studies is retro-
spective, time spent performing ET in the 
cited studies was too big (two to ten days), 
while non-homogeneous groups of patients 
made it difficult to interpret the results. 
Most studies did not precisely explain how 
randomization of patients was done, or the 
criteria according to which the patients 
were assessed for expected duration of me-
chanical ventilation. 
The primary objective of this study was to 
determine the differences in the incidence 
of respiratory infections and septic epi-
sodes in patients who underwent ET and 
in patients who underwent translaryngeal 
intubation i.e. LT. Secondary objectives 
were to determine the differences in early 
mortality of patients, duration of mechani-
cal ventilation and length of ICU stay.
MATERIALS AND METHODS
The study included 72 surgical and trauma 
patients older than 18 years of age, treated 
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at the ICU of the University Clinical Hos-
pital Mostar who underwent translaryn-
geal intubation and were mechanically 
ventilated for at least 48 hours. 
The study was approved by the Ethics 
Committee of the University Clinical Hos-
pital Mostar (3108/13,29.05.2013).
The basic criterion for inclusion in the 
study was the expected duration of me-
chanical ventilation for at least 14 days 
based on the diagnosis of patients SOFA 
score >5, APACHE II scores >10, PaO2 
≤60 mmHg with FiO2 0.5 and PEEP of at 
least 8 cm H2O. Patients who had already 
undergone tracheotomy, patients with a 
history of anatomical deformity of the 
neck, or suffering from hematologic malig-
nancies and patients who were diagnosed 
with a respiratory infection within the first 
48 h of mechanical ventilation were all ex-
cluded from the study. Due to the specific 
condition of patients, informed written 
consent for participation in the study was 
signed by a member of the patient’s imme-
diate family. 
Forty-eight hours after enrollment, pa-
tients were randomly divided into two 
groups. The first group of patients under-
went early tracheotomy (ET) after 2-4 days 
of mechanical ventilation, while the pa-
tients in the second group were ventilated 
through the endotracheal tube. The pa-
tients in the second group underwent late 
tracheotomy (LT) if they exhibited longer 
episodes of hypoxemia after 15 days, iden-
tified as PaO2 <60 mmHg with FiO2 0.6 
and PEEP = 8 cm. 
Percutaneous dilatational tracheotomy 
was performed in the ICU. Over the treat-
ment course, all complications related to 
tracheotomy were noted and classified as:
1. intraoperative: minor or significant 
bleeding, difficult tracheotomy tube 
placement (i.e., requiring >2 attempts 
at insertion during primary placement 
procedure), hypoxia (oxygen saturation 
of<90% for 60 sec) and arrhythmia.
2. post-operative: inflammatory changes 
around the stoma, pneumothorax, sub-
cutaneous emphysema, tracheoesopha-
geal fistula, cannula displacement, and 
the need for cannula replacement. 
All patients were assessed according to the 
APACHE II score upon admittance to the 
ICU, while SOFA scores were determined 
48 h after the start of ventilation. All pa-
tients were mechanically ventilated with 
ventilator settings (tidal volume 6-7ml/kg, 
peak pressure <35 cm, PEEP >5 cm H2O) 
in accordance with good clinical practice. 
The process of weaning from the ventila-
tor was done according to the algorithm of 
gradually reducing ventilator support dur-
ing pressure support ventilation (PSV). 
At the start of the study, every patient was 
classified according to: age, gender, pri-
mary diagnosis, type of surgical procedure 
(abdominal or urological, neurological, 
vascular), emergency or elective surgical 
procedure. In addition a complete hema-
tological and biochemical analysis and 
surveillance cultures of nasal and rectum 
swabs were performed. All patients under-
went qualitative and quantitative analysis 
of bronchial secretions using the bron-
choalveolar lavage technique 48 hours 
after the start of mechanical ventilation. 
Ventilator associated pneumonia (VAP) 
was diagnosed based on standardized cri-
teria: body temperature <38 or >36, pu-
rulent bronchial secretions, new lung in-
filtrate observed on X-ray, qualitative and 
quantitative microbiological analysis of 
the bronchial secretion obtained by bron-
choalveolar lavage and laboratory diagnos-
tics (leucocyte count, C-reactive protein, 
etc). (11) 
Septic episodes were diagnosed based 
on: clinical symptoms, laboratory results, 
hemodynamic parameters and microbio-
logical analysis in accordance with usual 
clinical practice, as well as on established 
criteria for the diagnosis of sepsis: tem-
perature >38°C or <36°C, heart rate >90 
beats per minute, respiratory rate >20 
breaths per minute, abnormal white blood 
cell count >12,000/mm3 or <4,000/ mm3 
or >10% bands, occurrence of hypoperfu-
sion, hypotension and oliguria. (12) 
The occurrence of cardiac ischemia and 
arrhythmias was detected by constant elec-
trocardiographic (ECG) monitoring. Mi-
crobiological analysis of bronchial secre-
tions was done every three days in patients 
included in the study. For patients diag-
nosed with hospital ventilator associated 
pneumonia, the frequency of performing 
microbiological analysis of the bronchial 
secretion depended on the microbiologi-
cal lab results and clinical disease course. 
The dynamics of carrying out hematologi-
cal, biochemical and other microbiologi-
cal analysis was determined by the clinical 
condition of the patient. 
Microbiological analyses were performed 
at the Institute of Microbiology and Mo-
lecular Diagnostics of the University Clini-
cal Hospital Mostar in a way that patho-
gens were isolated and identified from 
the samples along with determining their 
potential resistance to certain antibiotics 
according to the antibiogram. Hematologi-
cal and biochemical results were collected 
at the Institute of Laboratory Diagnostics 
of the University Clinical Hospital Mo-
star. The following criteria were noted for 
every patient in both groups: the number 
of days on mechanical ventilation, the to-
tal number of ICU days, and the treatment 
outcome.
The study reported difficulties in wean-
ing the patients from the ventilator and 
incidences of re-intubation of patients. 
Bronchoscopic examination of the larynx 
and trachea was performed within 1 to 5 
days of removal of the cannula or endotra-
cheal tube and any probable functional or 
anatomical injuries were recorded. We also 
noted clinical symptoms of dysphagia, dys-
phonia, dyspnea, etc. Data were collected 
by the physicians from the Department 
of Anesthesiology and Reanimation and 
Intensive Care of the University Clinical 
Hospital Mostar, while percutaneous tra-
cheostomy was performed by the same and 
experienced ICU attending physician. 
A software system SPSS forWindows(v
ersion17.0,SPSSInc., Chicago, Illinois, 
USA) and MicrosoftExcel (version Office 
2007,Redmond,WA,USA) was used for 
statistical analysis of the obtained data. 
Results of nominal characteristics are ex-
pressed as n (%), Chi-square test was used 
to test significant differences (if lack of 
expected frequency occurred the Fisher’s 
exact test was used). Kolmogorov-Smirnov 
test was used to test concurrency of in-
terval characteristics with normal distri-
bution. Characteristics which did not 
deviate from the normal distribution are 
expressed as mean and standard devia-
tion (M±SD), while t-Test was used to test 
significance of the difference between the 
means of two independent samples. Char-
acteristics which deviated from the normal 
distribution are expressed as median and 
interquartile range (C [IQ]) while Mann-
Whitney test was used to test significance 
of the difference. The level of significance 
was set at 0.050 while values which could 
not be expressed to three decimal places 
are reported as p<0.001.
RESULTS
Distribution of patients according to tra-
cheotomy and other analyzed parameters 
ispresented in Table 1.
There was no statistically significant dif-
ference between the observed groups 
in regards to gender (p=0.148) and me-
dian age (p=0.386) and APACHE II score 
(p=0.472). There wasno statistically sig-
nificant difference between the groups in 
the distribution of patients by predicted 
mortality rates according to APACHE II 
score (p=0.187). 
The difference found in the mean value 
       SIGNA VITAE    |    77
of the SOFA score between the observed 
groups is not statistically significant 
(p=0.213).
The difference found in the incidence of 
pneumonia among patients from the ob-
served groups is not statistically significant 
(p=0.128), but patients who underwent LT 
were found to be more likely to develop 
pneumonia than those who underwent ET 
(OR=2.000; 95% CI: 0.816-4.902).
Sepsis is more likely to occur in patients 
who had LT than in patients who had ET 
(OR=2.479; 95% CI: 0.995-6.176). The 
difference found is statistically significant 
(p=0.049).  
The ET group showed less mortal-
ity, the difference is statistically significant 
(p=0.028).
According to APACHE II score values, 
57.9% of patients who had ET are in the 
third mortality group. Distribution of pa-
tients by group and outcome shows that 
the portion of patients who died is 44.7% 
in the group of patients who underwent ET 
and 69.0% in the group of patients who un-
derwent LT. The actual mortality is much 
higher in the group of patients who had LT.
Length of ICU stay and duration of me-
chanical ventilation according to the 
groups are presented in Table 2.
The patients who had LT stayed in the ICU 
longer, and the difference found in the 
median length of ICU stay between the 
observed groups is statistically significant 
(p<0.001).
Patients who had LT were on mechani-
cal ventilation longer, and the difference 
found in the median duration of me-
chanical ventilation between the observed 
groups is statistically significant (p<0.001).
Adverse events associated with tracheoto-
my are indicated in Table 3.
Only one patient (2.38%) in the late tra-
cheotomy group experienced an adverse 
event.
DISCUSSION 
The benefits of tracheotomy include: im-
proved patient comfort due to reduction of 
oropharyngeal and laryngeal stimulation 
(and possibly less damage to the larynx), 
less need for sedation, improvement of 
pulmonary toilet, lower work of breath-
ing, faster weaning from mechanical ven-
tilation, lower risk of ventilator-associated 
pneumonia, and perhaps shorter duration 
of mechanical ventilation. By preventing 
microaspiration of secretions, tracheoto-
my might reduce VAP and septic episodes. 
Based on available data, we believe it is 
reasonable to perform early tracheotomy 
in all patients who require prolonged me-
chanical ventilation.
In most studies and meta analyses a com-
mon limitation is heterogeneity of studied 
populations, as well as methodological 
variability of the study population, such as 
time of ET, inclusion and exclusion crite-
ria, tracheotomy techniques etc.
Defining and predicting the need for 
prolonged ventilation has been a major 
methodological problem and challenge. 
The first question that arises is the follow-
Table 1. Distribution of patients according to the type of tracheotomy and analyzed pa-
rameters









Age C [IQ] 60.0 [13.0] 61.5 [28.0] 0.386‡













M±SD 23.61±8.14 22.36±7.32 0.472§






















Data are expressed as n (%), except where indicated otherwise
*Chi-square test;†Fisher's exact test; ‡Mann-Whitney U; §Student t test
ET, early tracheotomy; LT, late tracheotomy.
Table 2. Length of ICU (intensive care unit) stay and duration of mechanical ventilation 
according to group
Length of ICU stay Duration of mechanical ventilation
ET LT ET LT
n 38 42 38 42
Me 15.0 29.5 13.0 20.0
IQ 12.0 21.0 12.0 18.0
Min 5.0 4.0 3.0 4.0
Max 133.0 130. 110.0 110.0
Range 128.0 126.0 107.0 106.0
p<0.001* p<0.001*
*Mann-Whitney U
ET, early tracheotomy; LT, late tracheotomy
Table 3. Potential adverse side-effects associated with percutaneous tracheotomy
ET LT
N 38 42
Intraoperative Minor bleeding 0 1 (2.38)
Postoperative Stoma inflammation 0 0
Subcutaneous emphysema 0 0
Total 0 1 (2.38)
ET, early tracheotomy; LT, late tracheotomy
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ing: is it possible to prospectively identify 
patients who will require prolonged me-
chanical ventilation and could they po-
tentially benefit from tracheotomy? Most 
physicians base their decision to perform 
tracheotomy on subjective clinical criteria.
Seneff et al. attempted to develop a pre-
diction equation for a large population of 
mixed ICU patients. Using APACHE III 
score data from 6,000 ICU patients from 
40 United States’ hospitals the authors con-
ducted multivariate regression analysis to 
determine if particular patient or disease 
characteristics on ICU day one could be 
used to determine the duration of mechan-
ical ventilation. They found that the admit-
ting diagnosis and degree of physiological 
derangement measured by APACHE III 
score could accurately predict duration of 
mechanical ventilation (MV) in a group of 
ICU patients. (13)
Heffner et al. developed an acute respira-
tory distress syndrome (ARDS) predictive 
score. Predictor factors incorporated in the 
ARDS Score were collected on Day 4 and 
Day 7 in 50 patients with ARDS in criti-
cal care units of a large Academic Medical 
Center over a 4-year period. ARDS Score 
threshold of ≥2.5 accurately identified pa-
tients at risk of prolonged mechanical ven-
tilation. (14) 
Troche et al. confirmed that only emergen-
cy intubation and a lung injury score great-
er or equal to 1 independently predicted a 
duration of mechanical ventilation of more 
than 14 days. (15)
Terragni et al. estimated the need for pro-
longed mechanical ventilation according 
to objective criteria such as the severity of 
illness Simplified Acute Physiology Score 
(SAPS II) and SOFA score and the need for 
ventilator support required to obtain pre-
defining oxygenation criteria. (16)
Most studies included patients who were 
expected to require prolonged mechanical 
ventilation based on the clinical assess-
ment by the physician. (17)
In our study we proposed an early trache-
otomy decision algorithm based on objec-
tive criteria: APACHE II score >10, SOFA 
score >5 and a worsening of respiratory 
parameters as a valuable tool that my help 
us to predict the duration of mechanical 
ventilation in a select population of surgi-
cal patients.
The ideal time for performing tracheotomy 
remains controversial. The best timing of 
tracheotomy has changed over the last sev-
eral years and now many authors suggest 
performing early tracheotomy within 2–7 
days. (18)
Complications of prolonged endotracheal 
intubation include: dental damage, sinus 
obstruction, sinus infection, mouth injury, 
laryngeal trauma, cricoid cartilage dam-
age, tracheal injury (from cuff and tube 
tip). In addition to the other benefits of 
tracheostomy, the connection between the 
risk of larynotracheal injury and duration 
of intubation is important to take into con-
sideration in the timing of tracheostomy. 
Direct airway examination demonstrates 
marked airway changes within several days 
of translaringeal intubation. (18)
In our study, early tracheotomy was per-
formed within 2–4 days of mechanical 
ventilation to avoid the above mentioned 
complications.
We have observed a large difference in the 
incidence of pneumonia: 46.7% in the ET 
group versus 64.3% in the LT group but 
without statistical significance (p=0,056).
In their systematic review and meta-anal-
ysis, Liu et al. reported the crude cumula-
tive incidence of pneumonia as 35.9% in 
the ET group and 45.5% in the LT group. 
A pooled analysis was not performed sec-
ondary to significant heterogeneity of the 
measured effects between individual stud-
ies. (19)
Nseir et al. conducted a retrospective case 
– control study matching 177 patients who 
underwent tracheotomy with 177 control 
subjects treated with prolonged TLI. They 
found a statistically significant reduction 
in VAP episodes per 1 000 mechanical ven-
tilator days. The multivariate analysis of 
the study demonstrated that tracheotomy 
is independently associated with decreased 
risk for ventilator-associated pneumonia. 
(20)
The study by Rumbak et al. reported sig-
nificantly less pneumonia incidences (5% 
vs.25%) in the two groups of observed 
critically ill medical patients. (9) Zheng et 
al. report reduced incidences of ventilator 
associated pneumonia next to the above 
mentioned. (5)
Contrary to the above, Teragini et al. con-
ducted a randomized control study in 12 
ICUs and compared the incidences of 
hospital pneumonia in patients who un-
derwent ET (6-8 days after translaryngeal 
intubation) and in those patients who un-
derwent LT (15 days after translaryngeal 
intubation), and found no statistically sig-
nificant difference. (16) 
In a study conducted by Blot et al., the inci-
dence of hospital infection and the number 
of septic episodes did not statistically differ 
between the early tracheotomy group of 
patients and the one that underwent trans-
laryngeal intubation. Greater comfort was 
the sole benefit afforded by tracheotomy. 
(21)
Our study, like almost all other, reported a 
statistically significant shorter duration of 
mechanical ventilation and length of ICU 
stay in the ET group (11.00 and 13 days) 
versus LT group (20.00 and 29.5 days).
Liu et al. reported that the average dura-
tion of mechanical ventilation was 17 days 
for the ET group and 24 days for the LT 
group. The study results demonstrated that 
ET is significantly associated with shorter a 
ICU stay of 9.13 days. (19) 
Bourdeka et al. investigated if ET (fifth day) 
reduces duration of mechanical ventila-
tion. The study reported shorter mechani-
cal ventilation in ET group. After pneumo-
nia was diagnosed, mechanical ventilator 
time was 6±4.7 days for ET group versus 
11.7±6.7 days for patient endotrachealy in-
tubated or LT group. (22)
Rodriguez et al. prospectively randomized 
patients to receive either an ET (within 7 
days) or LT (greater than 7 days).  ET was 
associated with shorter ICU and hospital 
stay, and reduction in duration of mechan-
ical ventilation with a mean difference of 
– 20 days (95% CI: 20.8 to -19.2 (p<0.05). 
(23)
Rumbak et al. also found a decreased 
length of mechanical ventilation with 
a mean deference of – 9.8 days (95% CI: 
-11.5 to -8.12, p<0.001). The ET group 
spent less time in the intensive care unit 
(4.8±1.4 vs. 16.2±3.8 days) and on me-
chanical ventilation (7.6±2.0 vs. 17.4±5.3 
days). The generalizability of this study is 
limited by inclusion of only a very specific 
group of severely ill medical patients. (9) 
Griffiths and al. analyzed 5 trials in which 
ET was performed within 1-7 of mechani-
cal ventilation or ICU admission. The study 
participants included general trauma, 
head trauma, surgical, medical and burn 
patients. The meta-analysis demonstrated 
faster weaning and shorter duration of me-
chanical ventilation and ICU stay. (24)
Young and al. did not find a significant 
reduction in the duration of mechanical 
ventilation with a mean difference of 1.6 
days. (25)
The effect of tracheotomy on intensive care 
unit, hospital and overall mortality is also 
controversial.
In most published studies mortality was 
defined as hospital mortality. The defini-
tion included usually ICU, 28 and 30 day 
mortality and hospital mortality. Hospital 
mortality of our patients was 46.70% in 
ET and 69.00% in the LT group. The main 
cause of death was sepsis 43.30% in ET 
group and 69.00% in LT group. 
Liu and al. reported mortality data from 
eight studies. The percentage of patients 
who died in the early tracheotomy group 
was 30.7% compared with 34.7% in the late 
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tracheotomy group. The weighted absolute 
and relative risk reduction was not signifi-
cant. Soubgroup analysis did not suggest a 
difference in outcome based on etiology of 
critical illness or whether the ET was per-
formed at 2 to 3 days, 4 to 5 days or 7 to 8 
days of endotracheal intubation. (19) 
A prospective, randomized study by Blot et 
al. found no difference for a 28 – day mor-
tality in 123 patients included in the study 
20% in ET group and 24% in LT group. 
(21) Two single center studies by Koch et 
al. and Zheng et al. also did not show a sur-
vival benefit for ET. In a multicenter non-
randomized, propensity matched com-
parison, Clech et al. found no difference in 
critical care unit mortality. (6,5,26)
A further study by Scales et al. performed 
a stratified propensity score analysis from 
a local database and reported a small in-
crease in long term mortality in the ET, but 
the increase was of questionable clinical 
significance. (27)
Prospective and randomized study by 
Rumbak et al. included 120 medical pa-
tients in the ICUs. Patients were critically 
ill with APACHE II score >25.50% were 
chronic obstructive pulmonary disease 
(COPD) patients. ET was performed 
within 2 days of admission while LT was 
done at days 14-16. In that study the pro-
jected need for prolonged intubation was 
indicated as specific inclusion criteria, but 
Rumbak did not describe the method by 
which these patients were identified. Early 
group showed significantly less mortality 
(31.7% vs. 61.7%). The generalizability of 
this study is limited by inclusion of only a 
very specific group of severely ill medical 
patients. (9)
The meta analysis of Dunham et al. in-
cluded 5 studies of high-quality design. 
Early tracheotomy was performed within 5 
days from the start of mechanical ventila-
tion in a group of trauma patients. There 
was no statistically significant difference in 
the risk of developing pneumonia and du-
ration of mechanical ventilation but mor-
tality was significantly lower and ICU stay 
significantly shorter in ET group. (28) 
Frutos Vivar et al. found lower ICU mor-
tality rate in patients undergoing tracheot-
omy (20% vs. 32%) but hospital mortality 
was not different between the groups. (29) 
Wang et al. in a systematic review and me-
ta-analysis of seven randomized control 
trials with 1044 patients concluded that 
the timing of tracheotomy did not signifi-
cantly alter important clinical outcomes of 
the patients-short and long term mortal-
ity and incidence of ventilator –associated 
pneumonia. (30)
Most of the meta analysis and RCT trials 
published on ET have found no important 
benefits with ET. There was no difference 
in hospital mortality and there was not 
enough evidence to support ET with re-
gard to the incidence of VAP. In most stud-
ies ET was significantly associated with a 
decreased length of ICU and hospital stay 
and length of mechanical ventilation. The 
literature on this topic is difficult to inter-
pret because of varying definition of early 
tracheotomy 0 to 7 days and inhomoge-
neous groups of patients, different inclu-
sion and exclusion criteria, randomization 
techniques, different weaning protocols 
and because some of the studies are retro-
spective. 
The most important limitation of our study 
is the small number of included patients, 
leading to underpowered (unsupported) 
results. In addition, the study is limited by 
being a single – center study. 
On the other hand, we believe that our 
study is free of the main methodological 
problems. We have a homogenous popula-
tion in terms of pathology and in terms of 
severity of illness because we used objec-
tive inclusion criteria in the study popula-
tions and we precisely defined the timing 
for performing ET. 
The results of our study support ET per-
formed 2 – 4 days from the start of mechan-
ical ventilation in regards to the length of 
mechanical ventilation and length of ICU 
stay. Despite the lack of power, we found 
significant benefits of early tracheotomy 
regarding the incidence of pneumonia, 
sepsis and hospital mortality. 
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